eisai co ltd (4523:Tokyo Stock Exchange)
Representative Corporate Officer of Healthcare Policy & China Business,Eisai Co., Ltd.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 1 different industries.|
Mr. Yutaka Tsuchiya serves as a Representative Corporate Officer of Healthcare Policy & China Business at Eisai Co., Ltd. and served as its Representative Corporate Officer. Mr. Tsuchiya served as Deputy President and Marketing Authorization Supervisor General of Global Product Emergency Management for Healthcare Policy - Chief Executive Officer's special mission at Eisai Co. Ltd. Mr. Tsuchiya served as an Executive Vice President of Eisai Co. Ltd. and served as its ...
4-6-10, KoishikawaPhone: 81 3 3817 3016
Tokyo, -- 112-8088
Fax: 81 3 3811 6032
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
Other Affiliations*There is no Company Affiliations data available.
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Michael W. Aguiar||Chief Executive Officer, President, Director and Member of Stock Option Committee|
|Howard W. Robin||Chief Executive Officer, President and Director|
|Peter M. Hecht Ph.D.||Co-Founder, Chief Executive Officer and Director|
Ironwood Pharmaceuticals, Inc.
|Akira Kurokawa||Chief Executive Officer, President, Representative Director, Member of Nominating Committee, Member of Executive Compensation Committee and Member of Corporate Strategy Committee|
Santen Pharmaceutical Co. Ltd.
|Eduardo Javier Sanchiz Yrazu||Chief Executive Officer, Member of Management Board, Executive Director and Member of Compliance Committee|
|€1.1M||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.